Final ASTRUM-002 Analysis Shows Survival Benefit with Hetronifly in Advanced nsqNSCLC After Four Years of Follow-Up
SHANGHAI, CHINA, August 10, 2026 /EINPresswire.com/ -- Shanghai Henlius Biotech, Inc. (2696.HK), headquartered in Shanghai and listed on the Hong Kong Stock Exchange, recently announced definitive final survival findings from its proprietary anti …